Centene Corporation

Equities

CNC

US15135B1017

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
78.35 USD +1.02% Intraday chart for Centene Corporation +0.60% +5.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Markets Steady -2- DJ
North American Morning Briefing : Stocks Struggle -2- DJ
Stephens Downgrades Centene to Equal-Weight From Overweight, Cuts Price Target to $85 From $92 MT
Wells Fargo Raises Centene's Price Target to $94 From $90, Maintains Overweight Rating MT
Transcript : Centene Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:00 AM
Barclays Initiates Centene With Overweight Rating, Price Target is $101 MT
Centene Insider Sold Shares Worth $774,100, According to a Recent SEC Filing MT
Centene Insider Sold Shares Worth $900,818, According to a Recent SEC Filing MT
Global markets live: BP, Palantir, Infineon, Toyota, UBS... Our Logo
Tranche Update on Centene Corporation's Equity Buyback Plan announced on November 7, 2005. CI
Sector Update: Health Care Stocks Gain Premarket Tuesday MT
Wall St set for muted open; earnings, rate-cut expectations in focus RE
Transcript : Centene Corporation, 2023 Earnings Call, Feb 06, 2024
Stocks Decline Pre-Bell as Traders Await More Earnings; Asia Mostly Down, Europe Gains MT
Centene's Q4 Adjusted Earnings Decline, Revenue Increases MT
Earnings Flash (CNC) CENTENE CORPORATION Reports Q4 Revenue $39.46B, vs. Street Est of $35.72B MT
Earnings Flash (CNC) CENTENE CORPORATION Posts Q4 EPS $0.45, vs. Street Est of $0.44 MT
Futures subdued with focus on pharma earnings, rate expectations RE
North American Morning Briefing : Rate Doubts Keep -2- DJ
Centene quarterly profit beats estimates on higher demand RE
Centene Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Centene Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024 CI
MORNING BID AMERICAS-Rates rebound cools, China commands rally RE
Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business CI
Chart Centene Corporation
More charts
Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
78.35 USD
Average target price
89.02 USD
Spread / Average Target
+13.62%
Consensus
  1. Stock
  2. Equities
  3. Stock Centene Corporation - Nyse
  4. News Centene Corporation
  5. Centene : Insider at Centene (CNC) Makes Significant Sale of Stock